EUVIMEDSkopri EUVIMED
Open access · CC BY-NC-ND 4.0

Short Report: Hospitalization for New-Onset Heart Failure in Survivors of Hospitalized COVID-19

Vicente Corrales-Medina, Jordana B Cohen, Seavmeiyin Kun, Bianca Pourmussa, Ozgun Erten, Joe-David Azzo, Julio A Chirinos

ESC Heart Failure · 2025

DOI: 10.1002/ehf2.15331 ↗

At a glance

Journal article in ESC Heart Failure, 2025. Written by Vicente Corrales-Medina and 6 co-authors. Institution: The Ottawa Hospital Research Institute and University of Ottawa, Ottawa, Ontario, Canada. Major MEDLINE topics: COVID-19, Heart Failure, Hospitalization, Survivors. Cited 2 times so far (Crossref); 18 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NHLBI NIH HHS.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Aims

Previous studies have reported an incidence of new-onset heart failure (HF) among COVID-19 survivors ranging from 0.7 to 8.5 per 100 person-years, but they relied on administrative data for outcome ascertainment. Given the public health implications, a more accurate characterization of the HF burden post-COVID-19 is important. Methods and results We conducted a prospective cohort study of survivors of hospitalized COVID-19 and tracked the incidence of new-onset HF hospitalizations over the 12-month period following the index COVID-19 episode. Outcome ascertainment was based on a combination of chart reviews, patient interviews, and pre-specified clinical, radiographic and laboratory criteria. We identified 2140 survivors of COVID-19 hospitalization that were free of HF at the time of discharge. Their mean age was 67 years and 48% were Black/African-Americans. The incidence rate of hospitalized new-onset HF was 0.5 per 100 person-years. Higher BMI and dialysis dependency at baseline were significantly associated with HF development. The 1-year mortality rate was 3%.

Conclusions

The incidence of new-onset HF post-COVID-19 in our study was lower than in previous reports, despite involving an older population with more comorbidities and/or more severe COVID-19 overall. Reliance on administrative data for outcome adjudication in prior studies may have led to an overestimation of the HF burden post-COVID-19.

Subjects

MeSH terms (MEDLINE)

COVID-19Heart FailureHospitalizationSurvivorsHumansAgedMaleFemaleProspective StudiesIncidenceMiddle AgedSARS-CoV-2Aged, 80 and over

Author keywords

COVID‐19COVID‐19 survivorsHeart failure

Authors and institutions

  • The Ottawa Hospital Research Institute and University of Ottawa, Ottawa, Ontario, Canada.
  • University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Funding

  • NHLBI NIH HHS

Cite

APA

Corrales-Medina, V., Cohen, J. B., Kun, S., Pourmussa, B., Erten, O., Azzo, J. D., & Chirinos, J. A. (2025). Short Report: Hospitalization for New-Onset Heart Failure in Survivors of Hospitalized COVID-19. ESC Heart Failure. https://doi.org/10.1002/ehf2.15331

Vancouver

Corrales-Medina V, Cohen JB, Kun S, Pourmussa B, Erten O, Azzo JD, et al. Short Report: Hospitalization for New-Onset Heart Failure in Survivors of Hospitalized COVID-19. ESC Heart Failure. 2025. doi:10.1002/ehf2.15331

BibTeX
@article{CorralesMedina2025,
  author = {Corrales-Medina, Vicente and Cohen, Jordana B and Kun, Seavmeiyin and Pourmussa, Bianca and Erten, Ozgun and Azzo, Joe-David and Chirinos, Julio A},
  title = {Short Report: Hospitalization for New-Onset Heart Failure in Survivors of Hospitalized COVID-19},
  journal = {ESC Heart Failure},
  year = {2025},
  doi = {10.1002/ehf2.15331}
}
Start for free →